首页> Annals of oncology : official journal of the European Society for Medical Oncology> Very high quantitative tumor HER2 content and outcome in early breast cancer.

Very high quantitative tumor HER2 content and outcome in early breast cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： H,Joensuu

第一单位： Department of Oncology, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland. Electronic address: heikki.joensuu@hus.fi.

作者： H,Joensuu ^[1] ; J,Sperinde ^[2] ; M,Leinonen ^[3] ; W,Huang ^[4] ; J,Weidler ^[4] ; P,Bono ^[5] ; V,Kataja ^[6] ; R,Kokko ^[7] ; T,Turpeenniemi-Hujanen ^[8] ; S,Jyrkkiö ^[9] ; J,Isola ^[10] ; P-L,Kellokumpu-Lehtinen ^[11] ; A,Paquet ^[4] ; Y,Lie ^[4] ; M,Bates ^[4]

作者单位： Department of Oncology, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland. Electronic address: heikki.joensuu@hus.fi. ^[1] Division of Research and Development, Monogram Biosciences, Inc., South San Francisco, USA. ^[2] 4Pharma, Turku, Finland. ^[3] Division of Clinical Research, Monogram Biosciences, Inc., South San Francisco, USA. ^[4] Department of Oncology, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland. ^[5] Department of Oncology, Kuopio University Hospital, Kuopio, and Vaasa Central Hospital, Vaasa. ^[6] Department of Oncology, Kanta-Häme Central Hospital, Hämeenlinna. ^[7] Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu. ^[8] Department of Oncology, Turku University Central Hospital, Turku. ^[9] Laboratory of Cancer Biology, Institute of Medical Technology, University of Tampere and Tampere University Hospital. ^[10] Department of Oncology, Tampere University Hospital, Tampere, Finland. ^[11]